BIOVENTUS INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+96.5% +$19M
$38M
Free Cash Flow↑+99.4% +$19M
$37M
Investing Cash Flow↑+17.4% +$174K
$-826K
Financing Cash Flow↑+122.3% +$5M
$947K
Capex↑+1.0% +$6K
$580K
Acquisitions
—
Stock-Based Comp↑+70.6% +$1M
$3M
Debt Repaid
—
D&A↓-5.7% -$711K
$12M
SBC Allocated Expense↓-31.3% -$1M
$3M